ONESTEP SCRIBE

The psychiatric discharge and transfer of care summary

By Selam Koch, PMHNP-BC, founder of OneStep Scribe and practicing psychiatric nurse practitioner. Published August 2026.

The psychiatric discharge and transfer summary - OneStep Scribe

Every psychiatric episode of care ends somewhere. Some endings are planned: the goals you set together are met and you schedule a last visit on purpose. Some are logistical: you are leaving, the patient is moving, the plan network changed. Some are fades, where the patient stopped scheduling in March and it is now August.

All of them need a written summary. In the charts I have reviewed, the planned ending is usually the only one that gets one, and often that is the last progress note with a sentence added.

The document is not for you. It is for a prescriber who has never met this person, reading your chart at 7:50 am with the patient already in the waiting room and nine minutes to get oriented. Every line should answer a question that clinician will have on day one.

What a discharge or transfer summary is

One document that closes an episode of outpatient psychiatric care and hands the clinical picture to whoever holds it next. Written once, at the end, covering the whole episode rather than one encounter. Four situations call for one:

The fourth is the one clinicians skip and the one with the most exposure, because the chart simply goes quiet. A chart that stops mid-sentence tells a later reader nothing about what you knew, what you tried, or what risk looked like when contact was lost.

How it differs from a final progress note

Question Final progress note Discharge or transfer summary
Time frame This encounter First visit to last contact
Primary reader You, at the next visit A clinician who has never met the patient
Medications Today's changes and rationale Every current drug with dose, route and frequency, plus what was tried and what happened
Risk As assessed today As of the last contact, dated, plus the pattern across the episode
What happens next Next appointment date Who holds this patient, how much medication they physically have, what is unresolved

Write it on the day of the last visit, as its own document or a clearly labelled section of the final note, and make it findable by name. A receiving office should not have to read fourteen progress notes to reconstruct a medication history.

The ten blocks

  1. Reason for summary. Planned ending, transfer, discharge or disengagement, with the dates the episode opened and closed and the date of the last actual contact.
  2. Course of treatment. Why the patient presented, the working formulation, what changed. Three to six sentences, not a visit-by-visit recap.
  3. Current diagnoses. Active as of the last contact, with ICD-10 codes that match the narrative. In the recurrent depression series a code states either a current severity or a remission status, never both, so a line reading moderate and in partial remission cannot be coded as written: when the picture moves into remission, the code moves with it. Carry the code that reflects the last contact, and say if a diagnosis was revised and why, because earlier claims carry the earlier code.
  4. Current medications. Each one with dose, route, frequency and the date started at that dose, plus relevant non-psychiatric medications and who prescribes them.
  5. Medication trial history and response. Highest value block, most often missing.
  6. Current risk status. As of the last contact, written fresh.
  7. Outstanding issues, written as tasks. Pending labs, a referral that had not landed, a monitoring interval coming due. Date each one, and give a pending authorization its denial date and its appeal deadline, because appeal windows are time limited: "branded formulation denied 22 Jul 2026, plan appeal window closes 20 Sep 2026, peer-to-peer not yet requested."
  8. Medication supply and bridging. What the patient physically has, and what you agreed to continue and until when.
  9. Follow-up plan. Who holds the patient now, whether that appointment is scheduled or only recommended, and what to do if things worsen first.
  10. Records. What was sent, to whom, on what date, through what channel, and what the patient received.

The trial history saves the next clinician a year

Without it, a new prescriber can re-try what already failed or spend three visits taking a medication history from someone who does not remember the doses. Write a compact ledger: drug, highest dose reached, how long at that dose, outcome, and why it stopped. The last column carries the meaning, because "stopped at week two for nausea" and "no response after eight weeks at full dose" say entirely different things about whether the drug is worth revisiting. Where a scale tracked response, say how the score moved, as in PHQ-9 and GAD-7 documentation. The fictional ledger below shows the format.

Medication Max dose Time at that dose Outcome Reason stopped
Sertraline 100 mg daily About 7 weeks Partial, PHQ-9 fell from the severe band to the moderate band Sexual side effects, patient declined to continue
Bupropion XL 150 mg daily About 10 days Not assessable, inadequate trial Increased anxiety and initial insomnia
Duloxetine 60 mg daily Ongoing, about 4.5 months Good, PHQ-9 in the mild band at the last three visits Current

Medication supply and refill bridging

This is the operational half of a transfer, and where patients actually get hurt. "Continue current medications" with no supply information leaves the next prescriber choosing between prescribing for someone they have not evaluated and letting a mood stabilizer lapse. Document three things:

Controlled substances get their own line: prescription drug monitoring program (PDMP) review date, quantity and dates of the last prescription, and any treatment agreement in place. Do not leave the receiving prescriber to infer the schedule of a stimulant or benzodiazepine from context.

Before you agree to bridge anything, confirm you may write it. A bridge prescription is a new prescription: it needs a current treatment relationship and, generally, licensure in the state where the patient is physically located when it is written, not the state you sit in. Controlled substances carry further federal and state limits on prescribing without a current qualifying evaluation, and those rules have changed repeatedly. Verify with your board and your own counsel rather than assuming a short bridge is exempt. If the patient has already moved outside your licensure, say so in the summary rather than promising what you cannot write.

The risk section must be current, not copied

Every other block is retrospective. This one is not. Copying a risk paragraph forward does the most damage of any shortcut here: it asserts a current risk level from information that may be months old, and the receiving clinician reads it as current. If your last real assessment was eleven weeks ago, say so, with the date. In your own words, give:

Keep the language behavioral and non-stigmatizing: what the person did, said and reported, not what they are. The underlying assessment structure is in suicide risk assessment documentation. The summary carries its conclusions forward with a date attached, not its paragraphs.

When the patient simply stopped coming

A patient who stops attending does not drop out of your responsibility because they stopped scheduling, and the chart should not go silent. Whether and when the relationship formally ends, and what notice or interim coverage you owe first, is a question for your state's law, your board and your own counsel, not something a chart entry settles. What the record can do is show what you knew, what you attempted, and where risk stood at the last contact.

Documented outreach comes before any closing summary. The chart should show:

If risk was elevated at the last contact, outreach and a summary are not the response. Escalate first: repeated contact attempts, contact with an authorized emergency contact, and, where indicated, a welfare check or emergency services. When you may contact a third party to reach a patient at risk is governed by state law, board rules and practice policy, so set that pathway with counsel in advance rather than deciding it under pressure. Crisis resources including the 988 Suicide and Crisis Lifeline belong in any written outreach. Close the episode only after that pathway has been worked and documented.

The mechanics of logging missed visits are in no-show and late cancellation documentation, and anyone you reached on the patient's behalf belongs in collateral contact documentation.

The closing summary then reads differently from a planned one. It states that the episode ended without a final visit, dates the last clinical contact, and separates what you knew from what you are assuming: "last clinical contact 12 Mar 2026, risk assessed low at that time, status since unknown" rather than a present tense claim about someone you have not seen in five months. Everything after that date is unknown, and the document should say so in those words.

A note on minors

Transfers of patients under 18 raise questions this article cannot answer for you. Who signs the authorization, what an adolescent may consent to or authorize alone, and what material disclosed to you in confidence may appear in a document a parent or guardian will read, are set by state law and vary considerably. Some categories, including substance use treatment, are separately protected. Settle your approach in writing with counsel before you are standing in a last visit holding a release form, apply it the same way for every adolescent, and note which consent pathway you used.

Termination, discharge and the question of abandonment

Whether a patient may be discharged, on what notice, with what interim coverage, and with what duty to assist in finding another prescriber, is governed by your state's law, your board's rules, your malpractice carrier and your payer contracts. Those vary by state and profession and they change. This article does not tell you when discharge is permissible, and no article should. Take that decision to your board's published guidance, your carrier and your own counsel.

What I can describe is what reviewers and receiving clinicians commonly look for in the chart. This is a documentation list, not a legal standard: a complete chart does not by itself establish that a discharge was permissible, adequately noticed or clinically appropriate.

Write it in the neutral register you would want read aloud later. A summary that reads as annoyed with the patient is a bad document no matter how justified the annoyance was.

A fictional worked example

FICTIONAL EXAMPLE: TRANSFER OF CARE SUMMARY

Not a real patient. Details are invented for illustration.

REASON FOR SUMMARY

Transfer of care, patient relocating out of state effective 1 Sep 2026 at patient request. Episode of care 3 Feb 2026 to 12 Aug 2026. Last visit 12 Aug 2026.

COURSE OF TREATMENT

Presented in February with four months of low mood, anhedonia, early morning awakening and reduced work function after a job loss. PHQ-9 in the severe band at intake, moderate in April, mild in June, July and at the last visit. Duloxetine started in March after two earlier agents, sustained response from May. Weekly psychotherapy with an outside therapist throughout. No hospitalizations.

CURRENT DIAGNOSES

F33.41 major depressive disorder, recurrent, in partial remission. F41.1 generalized anxiety disorder. Coded F33.1, recurrent moderate, through April, revised to F33.41 in June once symptoms fell to the mild band and held. Working diagnosis was single episode until April, when the patient described a prior untreated episode at age 24.

CURRENT MEDICATIONS

Duloxetine 60 mg by mouth daily, at this dose since 28 Mar 2026. Hydroxyzine 25 mg by mouth at bedtime as needed, used about twice monthly by report. Levothyroxine 75 mcg daily, prescribed by primary care, not managed here.

MEDICATION TRIAL HISTORY

Sertraline to 100 mg daily for about seven weeks, partial response, stopped for sexual side effects. Bupropion XL 150 mg daily for about ten days, stopped for increased anxiety and initial insomnia, not an adequate trial. Duloxetine 60 mg daily since 28 Mar 2026, good response, current.

CURRENT RISK STATUS

Assessed at the last visit, 12 Aug 2026. Passive thoughts of not wanting to be alive present at intake, last endorsed in April, none since. No plan, no intent, no prior attempts, no acute means access, no firearms in the home. Protective factors: engaged in therapy, close relationship with sibling, future orientation about the move. Safety plan completed 17 Feb 2026, reviewed 21 Apr 2026, copy held by patient. Crisis instructions including 988 and local emergency services reviewed 12 Aug 2026. Historical risk factor: paternal uncle died by suicide. What would concern me here is a return of early morning awakening plus withdrawal from the sibling, which preceded the February presentation.

OUTSTANDING ISSUES

Metabolic panel and thyroid function ordered 29 Jul 2026, not yet drawn. Patient advised to complete these after the move and send results to the new prescriber. No pending authorizations.

MEDICATION SUPPLY AND BRIDGING

Duloxetine last filled 9 Aug 2026, 30 day supply, one refill remaining at the current pharmacy. Patient given the prescription details and advised to transfer that refill to a pharmacy in the new location on arrival; if the transfer is completed, supply runs to approximately 8 Oct 2026. Hydroxyzine last filled 22 Jun 2026, 30 tablets, no refills, about 20 on hand by report. No controlled substances this episode. No bridging prescriptions provided: this practice is not licensed in the receiving state.

FOLLOW-UP PLAN

Intake scheduled with a psychiatric prescriber in the new location for 22 Sep 2026, contact information given. Therapy continues by telehealth through September, the therapist having confirmed she may practice in the receiving state for that period, while a local referral is arranged. Patient instructed not to stop duloxetine abruptly, told what discontinuation symptoms to expect, and given crisis instructions including 988 and the nearest emergency department.

RECORDS

Release signed 12 Aug 2026 naming the receiving prescriber, per practice policy. Summary and last three progress notes sent 13 Aug 2026 through the practice's secure channel. Copy provided to the patient on request.

Why this matters. Each block answers a question the receiving prescriber would otherwise put to the patient and get half an answer to. The trial history stops bupropion being counted as a failed agent when it was never an adequate trial. The supply line gives a real date and names the step that date depends on. The diagnosis line shows the code moving with the clinical picture, which keeps the summary consistent with the claims already submitted. And the telehealth line is conditioned, not assumed: care continuing across a state line depends on licensure where the patient now is, checked before it is promised. See telehealth psychiatry documentation.

Practical points that make it usable

For the same discipline applied to one visit rather than a whole episode, see the annotated psychiatric progress note example.

Frequently asked questions

Is a discharge or transfer summary separately billable?

For the outpatient episode closure this article is about, it is generally part of the work of the last encounter rather than a separate service. Two guardrails. The final visit is still coded on its own merits, and appending a summary does not by itself support a higher level. And if you report a psychotherapy add-on with an evaluation and management service that day, the E/M level must be selected on medical decision making, not time, because the time supporting the add-on cannot also count toward the E/M. That pairing is worked through in billing 99214 with 90833, and the tier choice in 90833 vs 90836 vs 90838.

Two adjacent services are separately reportable, though neither belongs to an outpatient practice closing its own episode. The work of discharging a patient from an inpatient or observation stay is reported on its own, with two codes split by whether that day's work runs to 30 minutes or less or beyond it. Transitional care management after a facility discharge belongs to the clinician assuming post-discharge care, and carries its own requirements: an interactive contact inside two business days and a face to face visit inside 7 or 14 days depending on the code.

Does the time I spend writing it count toward the visit level?

For office and other outpatient E/M, total time on the date of the encounter already includes the reporting clinician's non-face-to-face work, including reviewing records and documenting in the chart, so a summary written the same day can count when time is the basis for the level. Time spent on any other date does not count. For standalone psychotherapy codes only face to face session time counts, so writing the summary afterwards never moves a 90834 into 90837 territory. Prolonged services are where Medicare and commercial rules genuinely diverge. Check your own contracts, and do not count on separate payment.

How many outreach attempts before I close out someone who stopped attending?

There is no number I can give you, and be skeptical of any article that gives one. Those expectations come from your state law, your board, your carrier and your practice's own written policy. Set that policy in advance with counsel, apply it consistently to every patient, and let the chart show you followed it.

Does the summary go to the patient, the new clinician, or both?

They are two different transactions. Federal privacy rules generally permit disclosure to another treating clinician for that clinician's treatment of the patient without a separate authorization. The exceptions matter in psychiatry: psychotherapy notes maintained separately from the record, records from a federally assisted substance use disorder program, and several state mental health confidentiality statutes are stricter. Many practices obtain a signed release at transfer as policy anyway, which is reasonable. Get it signed at the last visit rather than chasing it afterward, and confirm what applies to you with your privacy officer or your own counsel.

A patient asking for their own copy is exercising a right of access, not making a release request, so do not route them through a third party authorization form. Provide it in the form and format they ask for where you reasonably can, note the risks if they ask for unencrypted email, and log what was provided and when. If you think any part of a record should be withheld, raise it with your privacy officer or counsel before you withhold it. Either way, document what was sent, to whom and on what date.

The ending was conflictual. How much of that goes in?

The facts, in neutral language, and nothing more. What happened, when, what was communicated, what was offered. No characterization of the patient, no defensive narration, no speculation about motives. Whether financial or policy matters belong in the clinical record at all, or only in the administrative record, is a question for your practice policy and your carrier, and many keep them separate; if your policy puts it in the chart, state it as one neutral administrative fact. The clinical content should be as complete as it would be for any other patient, because the next clinician's needs did not change.

Related guides

OneStep Scribe drafts this documentation automatically.

OneStep Scribe is an AI scribe built for psychiatric prescribers. It listens to the visit, in person or over telehealth, and drafts the complete note from what occurred in the visit, including the telehealth details and a billing section, for your review and signature. Every account is NPI-verified.

Start a 14-day free trial

This article is educational and reflects one clinician's understanding of coding rules at the time of writing. It is not legal, billing, or payer-specific advice, and it does not guarantee reimbursement or audit outcomes. Coding rules, payer policies, and state and federal laws change; always verify current requirements with your payers, coding resources, and compliance advisors, and consult your licensing board(s), current DEA guidance, and a healthcare attorney for licensure, consent, and controlled-substance questions. CPT is a registered trademark of the American Medical Association.